Thrombotic thrombocytopenic purpura overview: Difference between revisions
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Thrombotic thrombocytopenic purpura}} | {{Thrombotic thrombocytopenic purpura}} | ||
{{CMG}} | {{CMG}} {{AE}} {{S.G.}} | ||
==Overview== | ==Overview== | ||
'''Thrombotic thrombocytopenic purpura''' ('''TTP''' or ''Moschcowitz disease'') is a [[rare disease|rare]] disorder of the [[coagulation|blood-coagulation]] system, causing multiple blood clots to form in blood vessels around the body.<ref name="MedPlus"> | '''Thrombotic thrombocytopenic purpura''' ('''TTP''' or ''Moschcowitz disease'') is a [[rare disease|rare]] disorder of the [[coagulation|blood-coagulation]] system, causing multiple blood clots to form in blood vessels around the body.<ref name="MedPlus"> |
Latest revision as of 19:24, 27 September 2018
Thrombotic thrombocytopenic purpura Microchapters |
Differentiating Thrombotic thrombocytopenic purpura from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Thrombotic thrombocytopenic purpura overview On the Web |
American Roentgen Ray Society Images of Thrombotic thrombocytopenic purpura overview |
Directions to Hospitals Treating Thrombotic thrombocytopenic purpura |
Risk calculators and risk factors for Thrombotic thrombocytopenic purpura overview |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Sogand Goudarzi, MD [2]
Overview
Thrombotic thrombocytopenic purpura (TTP or Moschcowitz disease) is a rare disorder of the blood-coagulation system, causing multiple blood clots to form in blood vessels around the body.[1] Most cases of TTP arise from deficiency or inhibition of the enzyme ADAMTS13, which is responsible for cleaving large multimers of von Willebrand factor.[2] This leads to hemolysis and end-organ damage, and may require plasmapheresis therapy.